Skip to main content
. 2022 Jun 7;14(2):196–206. doi: 10.4274/jcrpe.galenos.2022.2021-10-4

Table 4. The comparison of clinicopathological features, extent of surgery, ATA initial risk stratification, and response to treatment according to BRAFV600E mutation status.

graphic file with name JCRPE-14-196-g4.jpg